Sun Pharmaceuticals to sell some low priority Ranbaxy brands – The Economic Times

Posted On Sep 15 2016 by

#sun pharma products # Sun Pharmaceuticals to sell some low priority Ranbaxy brands MUMBAI: Drug maker Sun Pharmaceuticals has put on the block a bundle of Ranbaxy brands which are low priority in its domestic market strategy or which may overlap with its own products, top industry executives said. The country’s largest drug maker completed acquisition of Ranbaxy last year from its Japanese owner, Daiichi Sankyo. as part of a $4 billion all-stock deal. The Ranbaxy brands that Sun is looking to sell rake in about Rs 115 crore in annual sales and the company is expecting a valuation of …


Boehringer pharmaceuticals

Posted On Sep 15 2016 by

#boehringer pharmaceuticals # История В двух словах Value Through Innovation. The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 145 affiliates and a total of around 47,500 employees. The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine. Social responsibility is an important element of the corporate culture at Boehringer Ingelheim. This includes worldwide involvement in social projects, such as the initiative “Making more Health” and caring for the employees. Respect, …